NCT02787876View on ClinicalTrials.gov

Pegteograstim in Children With Solid Tumors

PHASE2UnknownINTERVENTIONAL

Enrollment

34

Participants

Timeline

Start Date

October 4, 2016

Primary Completion Date

October 31, 2018

Study Completion Date

November 30, 2018

Conditions

Chemotherapy Induced NeutropeniaPediatric Solid Tumor

Interventions

DRUG

Pegteograstim

Trial Locations (1)

Unknown

RECRUITING

Samsung Medical Center, Seoul

Sponsors

Collaborators (1)

Green Cross Corporation

All Listed Sponsors

collaborator

Green Cross Corporation

INDUSTRY

lead

Samsung Medical Center

OTHER